Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Herpes simplex virus DNA replication" is a biological process, not a discrete, single molecular target (such as a receptor, enzyme, or ion channel). The replication of herpes simplex virus (HSV), primarily HSV-1 and HSV-2, is mediated by a multisubunit complex of viral proteins (including origin binding protein UL9, single-stranded DNA binding protein ICP8, helicase-primase complex UL5/UL8/UL52, and DNA polymerase UL30/UL42) along with numerous interacting host proteins[1][3][5]. These proteins work together to recognize viral origins of replication, unwind DNA, synthesize RNA primers, and perform DNA polymerization, coordinating with repair and chromatin remodeling pathways[1][3][2][5]. Drugs targeting HSV replication, such as acyclovir, inhibit the viral DNA polymerase, a viral enzyme within this replication machinery. However, "herpes simplex virus replication" itself is not a single molecular entity and therefore is not considered a standard therapeutic "target" but rather a process targeted indirectly by drugs aimed at individual components (such as the viral DNA polymerase). Target assignment qualifications: - **is_incorrect** is true because "Herpes simplex virus replication" specifies a viral process, not a unique molecular target suitable for structured molecular target data collection. The correct molecular targets for drug intervention are individual viral proteins, especially the viral DNA polymerase (UL30), single-stranded binding protein (ICP8), and associated replication proteins[5][3][2]. - If the intention is to capture the actual druggable target, the entry should be changed to "Herpes simplex virus DNA polymerase" or a specific HSV replication protein[3][5].
Inhibition of viral DNA polymerase, leading to premature chain termination (e.g., acyclovir and derivatives); Inhibition of pyrophosphate binding site on DNA polymerase (e.g., foscarnet)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes simplex virus DNA replication machinery.